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MicroRNAs (miRNAs) are cell-endogenous small non-codingRNAs, which by 
mechanisms of RNA interference are involved in the post-transcriptional regulation of 
mRNAs. The biogenesis and function of miRNAs entail multiple elements with different 
alternative pathways. These, confer a high versatility of regulation and a high variability 
to generate different miRNAs and hence possess a broad potential to regulate gene 
expression. Here, we review the multiple, both canonical and non-canonical, mechanisms 
prevalent to generate miRNAs in animals. The “miRNome” panorama is enhancing our 
knowledge regarding the fine regulation of gene expression and is providing new insights 
concerning normal as opposed to pathological cell differentiation and development. 
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List of abbreviations: 
(ADAR) Adenosine Deaminases Acting on RNA: (AGO) Argonaute; (circRNAs) 
circular RNAs; (DGCR8) microprocessor complex subunit  DiGeorge syndrome Critical 
Region 8; (DICER) cytoplasmic endoribonuclease with dsRNA "dicing" activity; 
(dsRNA) double-stranded RNA; (DROSHA) double-stranded RNA-specific 
endoribonuclease nuclear type III, also known as RNASEN; (endo-siRNAs) 
endogenous-small-interfering RNAs; (miRNAs) microRNAs; (PAZ-domain) protein 
domain contained in the PIWI, ARGONAUTE and ZWILLE proteins, involved in post-
transcriptional gene silencing; (PTC) Papillary Thyroid Carcinoma; (piRNAs) piwi-
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interacting RNAs; (pri-miRNAs) primary miRNAs; (pre-RNAs) precursor-miRNAs; 
(RISC) RNA-Induced Silencing Complex; (SNPs) Single Nucleotide Polymorphisms; 
(snoRNAs) small nucleolar RNAs; (TUDOR) Tudor-staphylococcal nuclease.  
 
Introduction 
MicroRNAs (miRNAs) are small non-coding RNAs (≈21-23 nt) that act by 
RNA interference as post-transcriptional regulators of gene expression and play 
important roles in many developmental and cellular processes of eukaryotic organisms. 
Although the miRNA biogenesis pathways are similar in different phyla, there exist 
some differences between plants and animals that require a different study with respect 
to either biogenesis pathway [1]. We will focus in this review on the biogenesis of the 
miRNAs associated to the animal kingdom.  
MicroRNAs regulate negatively gene expression via base-pairing with 
complementary mRNA sequences in a mechanism named RNA interference. The 
interaction between miRNAs and their mRNA targets blocks the regular translation or 
induces the degradation of targeted mRNAs. MicroRNAs might regulate about 60% of 
mammalian coding genes and show specific profiles of expression at the level of cell 
types and developmental stages. Genes coding for miRNAs are scattered throughout 
mammalian genomes in intra- and intergenic positions. At present, 1,600 miRNA 
precursor molecules that generate 2,042 mature forms have been identified in the human 
genome (as to miRBase release 19) [2, 3]. Mouse and rat genomes encode 1,281 and 723 
mature miRNAs respectively [2, 3]. However, it is possible that the existing difference 
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with respect to the size of the human and rodent “miRNomes” results from a so far 
more exhaustive quest for human miRNAs. In fact, miRNAs are well conserved in 
eukaryotic organisms [4] and are thought to be the result of a vital and evolutionarily 
ancient component of genetic regulation.  
The binding of mature miRNAs to their target mRNAs occurs through a specific 
miRNA region of about 6-8 nucleotides in length. This region is termed the ‘seed region’ 
and allows for each of these small RNAs to regulate the expression of hundreds of genes, 
generally by binding to the mRNA 3’ UTR region. MicroRNAs that share a similar 
‘seed region’ belong to the same miRNA family. In general, members of a miRNA family 
regulate related genes or are involved in the regulation of similar biological events. Several 
families of miRNAs in mammals have been described, some of which are related to 
mechanisms of differentiation and self renewal and thus have been suggested as possible 
biomarkers for these types of processes. For example, the let-7 or miR-30 families 
promote differentiated cell fates while miR-290 family members are associated to self-
renewal events. 
Despite of the fact that miRNAs have been for the best characterized small non-
coding RNAs, some aspects of their biogenesis still remain to be uncovered. Recent 
studies have revealed alternative mechanisms of biogenesis and recycling of miRNAs [5-
11]. This review will mainly focus on the mechanisms of miRNA biogenesis generated 
by both canonical and non-canonical pathways. Furthermore, we will take in hand the 
study of miRNA recycling mechanisms and posttranscriptional modifications, due to 
the alternative processing of precursors and editing processes. Recycling mechanisms 
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allow the production of new mature miRNA molecules without a need to generate new 
miRNA precursors. 
 
The canonical miRNA biogenesis pathway  
Typically, miRNA biogenesis is directed through a specific promoter or as part 
of a host gene in which miRNA is usually enclosed within intronic regions. Some 
miRNAs are closely located in a genome and are transcribed as part of a common 
transcript (cluster of miRNAs), similar to polycistronic units [12, 13]. RNA 
polymerase II transcribes miRNA genes as large polyadenilated RNA molecules named 
primary miRNAs (pri-miRNAs) [14-16] (Fig. 1). These pri-miRNAs contain sequence 
complementary regions capable of materializing stem loops which include bulges and 
mismatches. Primary miRNAs are processed in the nucleus by a protein complex 
containing the RNase III enzyme DROSHA and DGCR8 [17, 18]. As result of this 
processing, pri-miRNAs are cleaved into smaller double-stranded RNA (dsRNA) 
molecules known as pre-microRNAs. In mammals and other vertebrates, together with 
flies pre-miRNAs are exported to the cytoplasm by exportin-5 (XPO5) [19-21]. In the 
cytoplasm, pre-microRNAs are cleaved and despoiled of their loops by the RNase III 
enzyme DICER, which through interaction with the protein TRBP produces double 
stranded RNAs characterized by overhangs of 2-3 nucleotides at both ends [22, 23]. 
These processed products are known as miRNA duplexes, as functional mature 
miRNAs are single stranded. The last processing step requires the active participation of 
a ribonucleoprotein complex known as RNA-induced silencing complex (RISC) which is 
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able to unwind both strands. Although either strand of the miRNA duplex could 
potentially act as a mature miRNA, usually only one of the strands is incorporated into 
the RISC complex to induce the mRNA silencing [24, 25]. The strand selection process 
is still a subject of study full of recurrent controversies [24-29]. Specificity of either 
strand has been associated to different cell types and developmental stages [30]. Once 
loaded, RISC mediates in the recognition of the mRNA to be targeted. 
Key components of the RISC complex are the Argonaute (AGO) family proteins 
[31-34]. Argonaute proteins bind to the different types of small non-coding interference 
RNAs such as: miRNAs, endogenous-small-interfering RNAs (endo-siRNAs) and piwi-
interacting RNAs (piRNAs). In mammals, seven Argonaute family proteins have been 
described. These proteins have been classified in two subfamilies known as the AGO 
subfamily and the PIWI subfamily [31-34]. The proteins encompassed in the AGO 
subfamily (AGO1-4) are involved in the miRNA and the endo-siRNA pathways, 
nonetheless, only AGO2 displays endonuclease activity [35-37]. On the contrary, PIWI 
proteins are only involved in the piRNA pathway. 
 
The non-canonical biogenesis of miRNAs 
In the past few years alternative sources of miRNAs have emerged. The 
biogenesis of such miRNAs entails some elements belonging to the canonical pathway 
but the genomic origin differs from that of the classical miRNAs (Fig. 1). Although most 
miRNAs are located in intergenic regions, some are derived from intragenic segments. A 
particular miRNA type derived from intra-transcribed loci is that known as mirtron 
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together with its variant called a sintrom. Mirtrons, localized in the intronic regions of 
mRNAs, can generate double stranded loop structures as do the regular miRNAs but are 
processed to pre-miRNAs by the spliceosome machinery (Fig 1). Their biogenesis 
pathway is DROSHA/DGCR8-independent as was demonstrated in Drosha mutants 
[38] and DGCR8 knockout cells [39, 40]. The existence of mirtrons, initially discovered 
in C. elegans and D. melanogaster [41, 42], has been demonstrated in different 
organisms from plants to mammals [43-45]. Following resolution of the intron lariat, the 
RNA product of splicing adopts a pre-miRNA like form, which can be further 
processed as a canonical pre-miRNA bound to XPO5, to then be transferred to the 
cytoplasm to continue with the canonical pathways (Fig. 1). The usual concept 
regarding a mirtron entails that the pre-miRNA-like mirtron is generated by the direct 
cleavage and excision within the splice donor and acceptor sites of the mRNA. That is, 
the splisosome machinery generates both prime ends of the pre-mirtron. However, not 
in all pre-mirtrons do the ends of the double stranded regions coincide with the ends of 
the intron. Some pre-mirtrons retain at the 3’or 5’ end a single stranded tail [39, 41, 46] 
which has to be processed before proceeding to the cytoplasmic export and cleavage by 
DICER. Such trimming is carried out by the action of the RNA exosome components, 
such as the Rrp6 nuclear exonuclease at the 3’ tail which stops its action at the 
secondary structure of the double-stranded stem of the pre-mirtron [46]. In vertebrates, 
5’ end tailed mirtrons have been identified [39, 47, 48], while 3’ tailed pre-mirtrons have 
only been detected in Drosophila. Specific exonuclease trimming of the 5’ end tailed pre-
mirtrons has not been identified yet. Identification by deep sequencing of mirtrons in 
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mammals [44] and the differences detected from those found in insects suggest a 
relatively late evolutionary diversification of mirtrons. 
 A recently discovered mirtron variants are the splicing-independent mirtron-like 
miRNAs, termed simtrons [49]. The main characteristics of this new variant of non-
canonical miRNA biogenesis are the spliceosome-independent but DROSHA-dependent 
processing of the pre-simtrons together with an XPO5 lack of dependence for transport 
to the cytoplasm. Replacement of DICER processing by AGO2 slicing of miRNAs was 
reported as a non-canonical alternative to the miRNA biogenesis of particular miRNA 
[36, 50-52] However, simtron processing are independent through DICER or AGO2. 
This novel type of a mirtron-like microRNA enhances the mechanisms that control the 
regulation of miRNA biogenesis and as a consequence the functional role of specific 
miRNA originated from such alternative mechanisms. 
 Other sources of miRNAs bypassing canonical biogenesis have also been 
described. Some small nucleolar RNAs (snoRNAs) can render miRNAs [53, 54], which 
are similar to mirtrons substrates for processing in a DICER-dependent and 
DROSHA/DGCR-independent pathway [55]. Transfer RNAs can also generate 
miRNAs which have to be sliced by DICER [56]. We have also recently identified some 
piRNAs in oocyte and sperm mouse cells with potential mRNA targets, in other words, 
with functional roles similar to miRNAs (manuscript submitted) [57]. 
 
Regulatory mechanisms involved in the miRNA biogenesis pathway 
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 The main regulatory mechanisms that operate in the canonical miRNA biogenesis 
pathway act on three levels: first, during the transcription of pri-microRNAs, second, 
by means of the editing mechanisms that can disrupt the processing of precursors and 
finally through the regulation of the processing machineries such as the 
DROSHA/DGCR8 complex or DICER.   
 With regard to the pri-microRNA regulation of transcription, in a manner similar 
to that of coding genes, it is mediated by transcription factors that are specific to cell 
types, respond to environmental stimuli or are necessary to trigger developmental 
pathways. For example, as to the transcription factors OCT4 and SOX2, which are 
involved in stem cell maintenance, these in turn also regulate the transcription of the 
mmu-miR-302 miRNA cluster [58-60]. Both OCT4 and SOX2 proteins bind to the 
conserved promoter region of miR-302 in a manner that miR-302 and their cluster 
partners are expressed in the same cells or tissues and at the same time as Oct4 and Sox2 
[61-63]. Another example regards the regulation of pri-miRNA-34 transcription by the 
P53 protein [64, 65]. In response to DNA damage, P53 is activated and acts on the 
promoter of miR-34 thus activating expression. It is thought that miR-34 induces the 
stop signals of the cell cycle pathway. Additionally, similar as occurs in protein-coding 
genes, the methylation of promoter regions can affect miRNA expression. For example, 
miRNAs involved in tumor suppression such as miR-148, miR-34b/c or miR-9 undergo 
aberrant hypermethylation patterns that have been associated to cancer disease [66-68]. 
The fact that the methylation of regulatory genome regions can also operate on the 
regulation of miRNA expression implies that the epigenetic modifications of the genome 
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at miRNA loci can induce additional check points with reference to epigenome 
regulatory mechanisms. 
 Precursor miRNAs can suffer sequence modifications by ‘editing’ before they 
are processed. The elicitors of the editing mechanisms are the protein family of the 
Adenosine Deaminases Acting on RNA (ADAR) [69-72]. The members of this family 
act on dsRNAs, including miRNAs, by modifying their nucleotide sequences. The 
editing process involves the specific deamination of one or more adenosine nucleotides 
by transforming adenosine into inosine (Fig. 1 and 2) [69-72]. Inosine is recognized by 
the translation machinery and in the RNA-RNA binding as nucleotide guanosine. 
However, it has been reported that the edition can disrupt the recognition of pri- and 
pre-miRNA by the DROSHA/DGCR8 and DICER processing machineries [73, 74]. 
Alternatively, when edition affects the seed sequence of mature miRNA it can cause a 
phenomenon known as retargeting [75, 76]. The editing mechanism will be discussed in 
detail further on. 
 Finally, the activity of DROSHA/DGCR8 and DICER can be regulated during 
the biogenesis of some miRNAs. For example, the ribonucleoprotein hnRNPA1 binds to 
the loop region of pri-microRNA-18a to facilitate its processing by DROSHA/DGCR8 
well ahead of their miRNA cluster partners (miR-17-92 cluster) [77, 78]. On the other 
hand, the activation of the ERK protein mediates the phosphorylation of TRBP by 
stabilizing the binding of pre-microRNAs with DICER [79]. As a result of this 
phosphorylation, the precursor molecule processing efficiencies are increased. Another 
example is the regulation of the let-7 biogenesis. The protein LIN28 represses both the 
processing of pri-microRNA to pre-microRNA of the let-7 microRNA as well as the 
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pre-microRNA-let-7 processing by DICER [80-82]. By a feedback mechanism, let-7 also 
regulates the translation of Lin28 mRNA [83].  
 
Bioavailability and miRNA recycling 
 The global bioavailability of miRNAs is presumably related to the availability of 
the different elements of the miRNA biogenesis machinery. Changes in the levels of 
expression of the genes encoding for the biogenesis and function of miRNAs can be 
modulated during development or cell type differentiation [84]. Key element depletion 
in the biogenesis pathway could condition the production stop of new mature miRNAs. 
Such switch-off mechanisms can comprise functional roles during cell differentiation and 
development which drive the reprogramming of the miRNA-mediated gene expression. 
For example, the suppression of the maternal program to initiate the zygotic activation 
program is one of the biological processes that occur during the early stages of embryo 
development after fertilization. The suppression of the miRNA activity during these 
stages in mammals was suggested by studies in Dgcr8−/− mutant mice. Following this 
line, we have also reported on the global decay of expression of genes involved in the 
canonical biogenesis pathway from fertilization to blastocyst mouse embryos [5]. 
However, a global lack of new miRNA biogenesis does not necessarily imply an absence 
of specific miRNA availability. We have previously demonstrated, that in early embryo 
stages in which expression of genes encoding proteins involved in the biogenesis of 
miRNAs was dramatically down-regulated, specific miRNAs such as mmu-miR-292-3p 
and mmu-miR-292-5p could be preserved as double stranded molecules by a ‘protection’ 
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through the binding to mRNA targets, pseudogenes, duplex passenger strands or other 
types of RNA-specific reservoirs [5] (Fig. 1). A similar miRNA protection by their 
heteroduplex cognate mRNA targets has also been reported in C. elegans [85]. Recent 
articles corroborate on the existence of such mature miRNA reservoirs in cells [7, 8, 86]. 
These reservoirs have the capacity to capture mature miRNA molecules to inhibit the 
miRNA silencing activities (Fig. 1). Some of these reservoirs are in fact RNA molecules 
that have a circular shape and can act as miRNA ´sponges´ in which the miRNAs could 
be stored until their hypothetical recycling [6]. This new type of RNA molecule has 
been given the name of circular RNAs (circRNAs) [7, 8].  
 Functional bioavailability of specific miRNAs can also be modulated by the 
regulation of endogenous elements able to ‘sequester’ miRNA molecules. This 
hypothesis has been demonstrated by the regulated expression of pseudogenes which 
share the 3’ UTR of their corresponding coding genes allowing the binding of miRNAs 
that are naturally involved in the post-transcriptional negative regulation of the coding 
genes. This fact has been reported in the up-regulation of PTEN caused by the over 
expression of PTENP1, a known PTEN pseudogene, resulting in the suppression of cell 
growth. In turn, PTEN mRNA can act as a decoy for miRNAs that would down-regulate 
PTENP1 transcripts [87]. 
 A yet poorly characterized aspect of miRNA activity is the fate of these small 
RNA molecules after eliciting the mRNA silencing. Furthermore, how the miRNA-
induced suppression finalizes, remains still an enigma. MicroRNAs have an unexpected 
long half-life and can reach high cell concentrations (Baccarini et al. 2011), even when 
key miRNA biogenesis elements such as DROSHA/DGCR8 or DICER are absent [88] 
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or show very low expression levels [89]. The existence of miRNA recycling pathways 
following the regulation of their targets facilitates their turnover. 
 One of the main features of miRNAs consists in their capacity to regulate 
multiple mRNA targets. However, the number of target transcripts in a cell often 
exceeds the number of miRNAs capable of regulating their transcripts [90]. It remains 
extremely difficult to explain how a relative low number of miRNAs are able to down-
regulate a large number of transcripts. The constant recycling of miRNAs derived from 
loci where mRNA target degradation is actively being carried out could explain the 
efficiency of miRNAs with regard to their gene silencing activities. Recycling 
exponentially increases the capacity of each mature miRNA molecule to regulate even 
hundreds of mRNA molecules without requiring a new processing of the miRNA 
precursor molecule. Nevertheless, where and how these miRNAs are stored until use 
remains poorly understood. The existence of molecular miRNA reservoirs, as mentioned 
above, could explain some of the peculiarities of the functional miRNA dynamics. 
Previous to the discovery of circRNAs, the possibility had already been suggested that 
mRNA targets could act as active reservoirs of the miRNAs that regulate them [89]. 
 In general, recent data has suggested that the interaction between miRNAs and 
their mRNA targets could be driven by dynamic ways. If the miRNA/mRNA interaction 
is the cause of target degradation, the miRNA could bind again to another, similar or 
different mRNA target molecule. Nonetheless, if the binding between the miRNA and its 
target inhibits translation without an mRNA cleavage, then the miRNA could keep on 
attached to the mRNA target and the mRNA would act as a reservoir of miRNAs. 
Finally, other types of RNAs such as pseudogene-coded mRNAs or circRNAs could 
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capture itinerant miRNAs, thus avoiding the interaction between miRNAs and their 
potential mRNA targets, which in response to demand could directly provide many 
functional and mature miRNAs. 
 
“One for all and all for one”: enhancing versatility 
 Based on the principles of miRNA-target recognition, on average each miRNA 
can recognize about 100-200 potential target sites of the transcriptome [91-93], 
considering only the seed region of the miRNAs and the 3’UTRs of the mRNAs, 
although additional interaction sites occur [94]. In turn, each transcript has various 
predicted and functional miRNA sites [91, 95, 96]. More than 50% of the human 
protein-coding genes contain conserved miRNA targeting sites [97]. This implies that 
the number of combinatorial miRNA-mRNA interactions enormously enhance 
regulatory possibilities. Moreover, this potential variability is further expanded if we 
consider the alternative transcription of genes coding for mRNA targets (such as SNPs, 
alternative polyadenylation sites and alternative splicing products) along with all the 
different alternative modifications that result from the miRNA alternative biogenesis 
mechanisms.  
MicroRNA editing  
 As dsRNAs, miRNA precursor molecules are targets of ADAR proteins. Recent 
evidences indicate that A-to-I editing of miRNA precursors (pri- and pre-miRNAs) 
affects both the miRNA function and biogenesis [98-100]. The editing of miRNA 
precursor molecules can alter the DROSHA/DGCR8 and DICER/TRBP recognition and 
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processing. Initially, evidence on miRNA editing was first observed during the 
processing of miR-22 [101] and was later also detected during the biogenesis of other 
miRNAs. Although, in the beginning it was suggested that miRNA precursor editing 
acted as a negative modulator of miRNA biogenesis, recently it has been demonstrated 
that the edited mature miRNAs can coexist with canonic mature miRNA molecules in 
the cell [74, 75, 102]. Actually, it has not been well established how the editing 
mechanisms trigger the elimination of miRNAs via TUDOR [99, 103] or, alternatively, 
modify miRNA precursors by changing their nucleotide sequence, to generate the 
alternative mature miRNA isoforms [75]. It seems that both routes act simultaneously. 
For example, research on miRNAs by deep sequencing in oocytes and zygotes revealed 
that mature miRNAs such as miR-376a, let7-g, miR-27a and miR-411, contained a 
considerable number of A-to-I sequence editions. In contrast, the edition levels of other 
miRNAs as for instance miR-151, miR-379 or miR-376b (-5p form) were low [75].  
 In general, the outcome of ADAR editing varies according to where the edited 
nucleotides are located. It has been established that the editing can impinge on the 
processing by DROSHA/DGCR8 and DICER/TRBP [100, 103]. However, is not yet 
clear whether edition results in a change of any recognition sequence into miRNA 
precursor molecules or if on the contrary the spatial conformation of miRNA molecules 
is changed. As dsRNA molecules, the pri- and pre-microRNA adopt tridimensional 
structures that could determine the accessibility of proteins involved in miRNA 
biogenesis. Secondary structures are also determined by the nucleotide sequence. In this 
manner, A-to-I editions can modify the secondary structure of precursor molecules, 
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hampering DROSHA/DGCR8 and DICER/TRBP recognition and in consequence 
hindering miRNA precursor processing.  
 The fate of the edited precursor molecules which are not processed has so far not 
been firmly established. Hypothetically, edited miRNA precursors could be maintained 
into cell reservoirs until needed for use as occurs with mature miRNAs. Nevertheless, 
the degradation of the edited-non-processed miRNA precursor molecules is so far the 
only mode reported [103]. For example, the editing of miR-142 precursor molecules 
blocks the DROSHA/DGCR8 pri-microRNA cleavage [100]. It has been observed that 
pri-miRNA-142 sequences displayed multiple A-to-I changes. These hyper-edited 
miRNA precursors were degraded via TUDOR-SN. This endonuclease recognizes 
inosine residues in dsRNAs and induces their cleavage [100, 103, 104]. Consequently, 
ADAR proteins could mark the miRNA precursor molecules that must be cleaved by 
hyper-editing their adenosines. It has not been well established how many A-to-I 
changes are necessary to promote the degradation of precursor miRNA molecules by 
TUDOR-SN. However, recently it was suggested that this degradation could occur for 
specific cytoplasm domains that have been named T-bodies (TUDOR-SN bodies) [75].   
 Nevertheless, editing can also modify the mature sequence of miRNAs. Such 
editions probably alter the function instead of the miRNA biogenesis. Due to the precise 
recognition requirement between the miRNA seed region and its specific target, A-to-I 
editions which affect the seed region can generate miRNA retargeting. However, both in 
mice and humans, editing and other polymorphisms are not promiscuously detected in 
the seed regions [75, 105], suggesting a strong selective constraint on the 
miRNA/mRNA recognition site. Finally, ADAR proteins can act directly on mRNAs 
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by modifying the recognition-site where the miRNA potentially bind [106]. This could 
also have an effect on the binding between the miRNA and their targets with regard to 
mRNA. 
IsomiRs 
Usually, miRNAs are annotated as a single defined sequence [107]. Using RNA-
sequencing, it has been observed that a pre-miRNA very often gives rise to more than 
one mature miRNA sequence [107-109]. These variants are named isomiRs and almost 
all of these molecules were initially considered to be artifacts [107, 110-112]. 
Nowadays, the capacity of isomiRs to be associated to RISC and to the translational 
machinery of polysomes has been demonstrated, further indicating that they could also 
interact with mRNAs [110, 113]. These miRNA variants can encompass substitutions, 
insertions or deletions (polymorphic isomiRs), 3´-isomirs and 5´-isomirs. 5´and 3´ 
isomiRs include non-template additions and 5´ - 3´ cleavage variations [107, 110] (Fig. 
2). 
In terms of the number of miRNAs and their overall abundance, the most 
common type of isomiR in animals and plants consist of the 3´ isomiRs [113-116]. As 
in regular miRNAs, isomiRs vary among different cells or tissues and according to 
specific biological stimuli [114-117]. This suggests that the presence of some isomiRs 
could be regulated according to different cell functions. 
5´ and 3´ template modifications  
It has been assumed that DICER needs a defined pre-miRNA distance of 22nt 
from the 5´ to the 3´end in order to be able to cleave both strands to produce a miRNA 
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duplex [118-121]. However, a high proportion of the identified isomiRs containing 5´ 
and 3´ modifications were derived from processing variations in the cleavage position of 
the precursor molecules by the DROSHA or DICER enzymes [107, 122, 123]. The 
most abundant isomiRs have been found to differ only by 1 or 2 nt at the 5’ -or 3’-end 
of their sequences [123]. These results have indicated that DROSHA is more specific 
than DICER during the cleavage process. In consequence, more variation with regard to 
cleavage sites occurs near to the loop as compared to the base of the stem in pre-miRNA 
hairpins. DICER´s cleavage imprecision can be explained by the simultaneous DICER 
protein recognition of the RNA-recognition PAZ domain and the RNAse III domain. 
DICER´s dual recognition permits to adopt a relatively flexible structure that 
accommodates pre-miRNA substrates, whereas the RNA recognition associated to 
DROSHA cleavage is provided only by protein DGCR8 [124, 125]. 
Changes of miRNA templates could also be associated to exoribonucleases. 
MicroRNAs bound to AGO proteins could be modified by nucleolytic trimming at the 
3´ ends to generate isomiRs. For example, in the Drosophila miRNA biogenesis 
pathway, Liu et al., (2011) [126] found that mir-34 displays multiple isoforms that 
differ at the 3’ end. These isoforms are produced by the action of the 3’ → 5’ 
exoribonuclease CG9247/NIBBLER. Trimming of miRNA at the 3’ ends occurs after 
removal of the passenger miRNA strand from the pre-RISC and may be the final step of 
the RISC assembly, ultimately enhancing the target [127]. 
5´ and 3´ non-template modifications 
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The 3´ ends of mature miRNAs are highly heterogeneous, whereas the 5´ ends 
which correspond to the seed regions are relatively invariable. The patterns and sources 
of heterogeneity seem to vary depending on the miRNA species and according to the cell 
type. The 3´ ends often contain 1 – 3 extra nucleotides that do not match with the 
genomic DNA sequences. Sequence alterations of miRNAs can occur by the addition of 
non-template nucleotides to the miRNA termini [111, 128]. The first description of a 3´ 
end modification of small RNA was rendered in the hen1 mutant of Arabidopsis [129]. 
HEN1 is a methyl transferase that adds a methyl group to the 2´-OH at the 3´ end of the 
RNA [130]. The addition of nucleotides is performed by a group of nucleotidyl 
transferases [131]. In humans there are twelve nucleotidyl transferases, seven of them 
are implicated in isomiR generation (reviewed by [107]). In both humans and mice, these 
enzymes have uridyltranferase and/or adenyltransferase activity which explain the most 
frequent non-template modifications such as insertions of single or multiple U 
(uridylation) or A (adenylation) [132]. Uridylation plays a significant role in the control 
of miRNA biogenesis. In mammalian embryonic stem cells, let-7 biogenesis is 
suppressed by the LIN28 protein which binds to the terminal loop of let-7 precursors 
[133, 134]. Of special interest remains the fact that LIN28 induces the 3´ uridylation of 
pre-let-7 by recruiting the terminal nucleotidyl transferase TUT4 [135]. The oligo U-tail 
added by TUT4 blocks the DICER processing mechanism and facilitates the decay of 
pre-let-7. In the case of the mammalian miR-122, which is adenylated by cytoplasmic 
poly (A) polymerase GLD-2 (or also TUTase2), 3´ end adenylation is also implicated in 
its stabilization [136]. Deep sequencing of the AGO-associated small RNAs has shown 
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that adenylated miRNAs are relatively depleted in the AGO2 and AGO3 complexes, 
whereby suggesting that adenylation may interfere with AGO loading.  
Single nucleotide polymorphisms (SNPs) 
Genetic variations range from large chromosomal anomalies to single nucleotide 
changes. SNPs are the most frequently identified variants of DNA sequences. SNPs 
affecting miRNAs could potentially affect the maturation process of miRNAs, the 
silencing machinery, the structure or the expression level of mature miRNA and the base 
pairing to target sites. Polymorphisms at a level of single nucleotides may also have 
functional roles in relation to miRNA-mediated gene regulation [137, 138]. Screening by 
numerous bioinformatics analyses has so far demonstrated only a very low density of 
SNPs in miRNA profiles [105, 139]. Polymorphisms in pre-miRNA may have an effect 
on miRNA maturation and thereby modulate miRNA expression. Several groups have 
tried to identify SNPs within or flanking pre-miRNA sequences using experimental or 
bioinformatics approaches. In one study, 173 human pre-miRNAs pertaining to 96 
Japanese individuals were sequenced, identifying 10 SNPs in 10 pre-miRNA hairpins 
[140]. Yet another study, identified 12 SNPs located within 227 human pre-miRNA 
sequences [141]. Borel et al. (2012) [142] detected sixty-five SNPs in 49 pre-miRNAs 
but only in the case of 3 pre-miRNAs (hsa-miR-125a, hsa-miR-627 and hsa-miR-662) 
were the SNPs located within the seed region [142], thus demonstrating that SNPs 
within miRNA seed regions are very rare (~6%). Furthermore, a G/U polymorphism, 
located at the eighth nucleotide within the mature sequence of miR-125a, has been 
functionally characterized to block the processing of pri-miRNA into pre-miRNA 
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altering the translation suppression of the mRNA target: Lin28 [141]. All of the above 
comprise good examples concerning the importance of the miRNA related SNP. 
Recently, the role of SNPs has been analyzed with reference to miRNA 
processing of cancer cells. For example, the hsa-miR-146a SNP (rs2910164) within the 
pre-miR146a sequence consists of one of the most thoroughly studied cases [137]. This 
SNP reduces both the amount of pre-miR146a and mature hsa-miR-146a affecting 
ultimately the DROSHA/DGCR8 cropping step, with consequent multiple associations 
to papillary thyroid carcinoma (PTC), familial/sporadic breast cancer, ovarian cancer, 
prostate cancer, and hepatocellular carcinoma [143-148]. In addition, SNPs of mRNA 
located in the 3’ UTR region of the specific binding site of miRNAs induce regulation 
pattern changes of the corresponding transcript. An SNP located in the KRAS 3’ UTR 
induces the over expression of KRAS, which has been correlated to an increased risk to 
acquire non-small cell lung cancer due to the lack of miRNA let-7 binding [149]. All of 
these studies have further contributed to the knowledge about miRNA binding site SNPs 
and cancer susceptibility; nonetheless, the need remains to carry out systematic studies 
to understand the role that SNPs play in connection to biological processes. 
 
Expert opinion 
The continuous progress in the quest to understand gene expression regulation 
mediated by small non-coding RNA, including miRNAs, is deeply revolutionizing our 
concepts in relation to the dynamics of functional genomics. The ubiquitous presence of 
these actors in the panorama of most biological processes, including pathologies, is 
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offering new visions, new experimental approaches and new perspectives with regard to 
the study of cellular and developmental biology. The multiple variants of the 
‘miRNome’ are enhancing the world of fine regulation, the diversity, as well as the 
response to environmental changes experienced by biological systems. However, both 
the biogenesis and the real functionality of some of the described and annotated 
miRNAs deposited in the miRNA databases (miRBase) will need a further re-definition 
as recently has already been proposed [150]. Comprehension of the functional roles and 
possibilities of gene regulation by miRNAs has only just initiated. 
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Figure legends 
Figure 1: MicroRNA biogenesis, degradation, storage and recycling. The figure 
illustrates the different pathways to generate functional miRNAs. 
 
Figure 2: Schematic representation of the different types of possible modifications to 
generate variations with respect to a hypothetical canonical sequence (22nt). 
 
 
 


